United States Biotechnology & Medical Research

Geron Corp (GERN)

Track

Track

Geron Corp has recorded no insider trading activity within the last ninety days. The most recent transaction occurred on February 18, 2026, when the Chief Financial Officer executed a sale of shares. Previous historical filings show a mix of buying and selling patterns among various corporate executives over the preceding two years.
Ticker: GERN Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Geron Corp. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
4.1
ROBERTSON MICHELLE EVP, CHIEF FINANCIAL OFFICER Officer
Transaction date
Sale
Price
294.90
Quantity 12,502 -47.9%
Value US$1,889,238
1.0
JAMES ZIEGLER Officer Officer
Transaction date
Proposed sale
Price
127.51
Quantity 41,867
Value US$395,014
3.1
LAWLIS V BRYAN Non-Executive Director
Transaction date
Purchase
Price
242.44
Quantity 23,533 +34.5%
Value US$2,231,583
0.7
SCARLETT JOHN A Chairman, President and CEO Executive Director
Transaction date
Purchase
Price
1.77
Quantity 12,500 +inf%
Value US$22,062
1.0
Ziegler James EVP, Chief Commercial Officer Officer
Transaction date
Purchase
Price
1.60
Quantity 100,000 +inf%
Value US$160,000
1.0
Samuels Scott Alan EVP, Chief Legal Officer Officer
Transaction date
Purchase
Price
1.61
Quantity 15,000 +128.4%
Value US$24,150
2.3
GRETHLEIN ANDREW J EVP, Chief Operating Officer Officer
Transaction date
Sale
Price
4.56
Quantity 674,348 -100.0%
Value US$3,073,004
2.3
GRETHLEIN ANDREW J Officer Officer
Transaction date
Proposed sale
Price
4.35
Quantity 674,348
Value US$2,933,414
2.7
Kapur Anil EVP, Corp Strategy & CCO Officer
Transaction date
Sale
Price
4.65
Quantity 421,875 -100.0%
Value US$1,959,609
2.7
Feller Faye EVP, Chief Medical Officer Officer
Transaction date
Sale
Price
4.63
Quantity 287,900 -100.0%
Value US$1,334,129
2.7
Feller Faye Officer Officer
Transaction date
Proposed sale
Price
4.65
Quantity 287,900
Value US$1,337,990
2.7
Kapur Anil Officer Officer
Transaction date
Proposed sale
Price
4.65
Quantity 421,875
Value US$1,961,941
0.7
SCARLETT JOHN A Chairman, President and CEO Executive Director
Transaction date
Planned sale
Price
4.00
Quantity 600,000 -50.0%
Value US$2,400,000
0.7
JOHN A SCARLETT Officer; Director Executive Director
Transaction date
Proposed sale
Price
4.00
Quantity 600,000
Value US$2,400,000
3.1
LAWLIS V BRYAN Non-Executive Director
Transaction date
Planned sale
Price
3.75
Quantity 35,000 -100.0%
Value US$131,250
3.1
BRYAN LAWLIS JR. Director Non-Executive Director
Transaction date
Proposed sale
Price
3.75
Quantity 35,000
Value US$131,274
2.5
O'Farrell Elizabeth G. Non-Executive Director
Transaction date
Purchase
Price
2.28
Quantity 6,579 +33.5%
Value US$15,000
2.5
O'Farrell Elizabeth G. Non-Executive Director
Transaction date
Purchase
Price
2.28
Quantity 6,607 +825.9%
Value US$15,064
3.1
BRYAN LAWLIS JR Director Non-Executive Director
Transaction date
Proposed sale
Price
3.00
Quantity 35,000
Value US$105,000
3.1
LAWLIS V BRYAN Non-Executive Director
Transaction date
Planned sale
Price
3.00
Quantity 35,000 -100.0%
Value US$105,000
SUSAN MOLINEAUX Director Non-Executive Director
Transaction date
Proposed sale
Price
2.48
Quantity 35,000
Value US$86,653
Molineaux Susan Non-Executive Director
Transaction date
Planned sale
Price
2.48
Quantity 35,000 -100.0%
Value US$86,800
0.7
SCARLETT JOHN A Chairman, President and CEO Executive Director
Transaction date
Planned sale
Price
3.00
Quantity 446,668 -100.0%
Value US$1,340,004
2.3
GRETHLEIN ANDREW J EVP, Chief Operating Officer Officer
Transaction date
Planned sale
Price
3.03
Quantity 234,719 -100.0%
Value US$711,199
2.3
GRETHLEIN ANDREW J EVP, Chief Operating Officer Officer
Transaction date
Planned sale
Price
3.03
Quantity 150,000 -39.0%
Value US$454,500
0.7
SCARLETT JOHN A Chairman, President and CEO Executive Director
Transaction date
Planned sale
Price
3.03
Quantity 446,666 -100.0%
Value US$1,353,398
Bloom Olivia Kyusuk EVP, Chief Financial Officer Officer
Transaction date
Planned sale
Price
3.08
Quantity 400,000 -84.3%
Value US$1,232,000
0.7
SCARLETT JOHN A Chairman, President and CEO Executive Director
Transaction date
Planned sale
Price
3.08
Quantity 446,666 -100.0%
Value US$1,375,731
2.5
O'Farrell Elizabeth G. Non-Executive Director
Transaction date
Purchase
Price
1.73
Quantity 17,441 +792.8%
Value US$30,173
2.5
O'Farrell Elizabeth G.
Transaction date
Purchase
Price
1.34
Quantity 2,200 +inf%
Value US$2,948
2.5
O'Farrell Elizabeth G.
Transaction date
Purchase
Price
1.35
Quantity 800 +inf%
Value US$1,080
BEHRS MELISSA KELLY EVP, Chief Business Officer
Transaction date
Planned sale
Price
2.00
Quantity 120,635 -100.0%
Value US$241,270
Spiegel Robert J. Non-Executive Director
Transaction date
Planned sale
Price
6.85
Quantity 35,000 -34.8%
Value US$239,750
Spiegel Robert J. Non-Executive Director
Transaction date
Planned sale
Price
6.85
Quantity 35,000 -34.8%
Value US$239,750
Spiegel Robert J. Non-Executive Director
Transaction date
Planned sale
Price
6.85
Quantity 35,000 -34.8%
Value US$239,750
Spiegel Robert J. Non-Executive Director
Transaction date
Planned sale
Price
6.85
Quantity 15,000 -18.6%
Value US$102,750
Spiegel Robert J. Non-Executive Director
Transaction date
Planned sale
Price
6.85
Quantity 10,000 -13.2%
Value US$68,500
Spiegel Robert J. Non-Executive Director
Transaction date
Planned sale
Price
6.85
Quantity 45,000 -40.7%
Value US$308,250
ROSENFIELD STEPHEN EVP, Genl Counsel & Secretary Officer
Transaction date
Planned sale
Price
4.51
Quantity 37,500 -100.0%
Value US$169,125
ROSENFIELD STEPHEN EVP, Genl Counsel & Secretary Officer
Transaction date
Planned sale
Price
4.51
Quantity 112,500 -100.0%
Value US$507,375
ROSENFIELD STEPHEN EVP, Genl Counsel & Secretary Officer
Transaction date
Planned sale
Price
4.51
Quantity 131,250 -100.0%
Value US$591,938
ROSENFIELD STEPHEN EVP, Genl Counsel & Secretary Officer
Transaction date
Planned sale
Price
4.51
Quantity 420,000 -100.0%
Value US$1,894,200
ROSENFIELD STEPHEN EVP, Genl Counsel & Secretary Officer
Transaction date
Planned sale
Price
4.51
Quantity 200,000 -100.0%
Value US$902,000
ROSENFIELD STEPHEN EVP, Genl Counsel & Secretary Officer
Transaction date
Planned sale
Price
4.51
Quantity 425,000 -100.0%
Value US$1,916,750
ROSENFIELD STEPHEN EVP, Genl Counsel & Secretary Officer
Transaction date
Planned sale
Price
4.51
Quantity 36,000 -100.0%
Value US$162,360
Hofstaetter Thomas Non-Executive Director
Transaction date
Sale
Price
4.10
Quantity 70,000 -72.5%
Value US$287,000
BRADBURY DANIEL Non-Executive Director
Transaction date
Purchase
Price
1.75
Quantity 142,776 +inf%
Value US$249,858
SCARLETT JOHN A President and CEO Executive Director
Transaction date
Purchase
Price
1.03
Quantity 50,000 +66.7%
Value US$51,500
BEHRS MELISSA KELLY SVP Alliance and Prog Mgmt Officer
Transaction date
Sale
Price
1.65
Quantity 28,292 -100.0%
Value US$46,569
KILEY THOMAS Non-Executive Director
Transaction date
Purchase
Price
1.56
Quantity 64,275 +25.7%
Value US$100,269
KILEY THOMAS Non-Executive Director
Transaction date
Purchase
Price
2.03
Quantity 50,000 +107.2%
Value US$101,500
BEHRS MELISSA KELLY SVP Oncology Officer
Transaction date
Sale
Price
8.12
Quantity 14,765 -100.0%
Value US$119,892
WALKER JOHN PETER Non-Executive Director
Transaction date
Sale
Price
8.28
Quantity 48,617 -55.4%
Value US$402,549
HARLEY CALVIN VP and CSO Officer
Transaction date
Sale
Price
7.08
Quantity 25,000 -20.1%
Value US$177,000
HARLEY CALVIN VP and CSO Officer
Transaction date
Sale
Price
7.14
Quantity 5,489 -4.2%
Value US$39,191
BEHRS MELISSA KELLY SVP Oncology Officer
Transaction date
Sale
Price
4.05
Quantity 23,845 -21.2%
Value US$96,572
EARP DAVID SVP Bus Dev, Chief Patnt Couns Officer
Transaction date
Sale
Price
5.34
Quantity 8,911 -5.4%
Value US$47,585
BEHRS MELISSA KELLY SVP Oncology Officer
Transaction date
Sale
Price
5.34
Quantity 8,911 -8.6%
Value US$47,585
LEBKOWSKI JANE SVP Regen Medicine Officer
Transaction date
Sale
Price
5.34
Quantity 8,911 -5.7%
Value US$47,585
GREENWOOD DAVID EVP and CFO Officer
Transaction date
Sale
Price
5.34
Quantity 11,039 -6.0%
Value US$58,948
HARLEY CALVIN VP and CSO Officer
Transaction date
Sale
Price
5.34
Quantity 8,911 -6.9%
Value US$47,585
OKARMA THOMAS President and CEO Officer
Transaction date
Sale
Price
5.34
Quantity 13,166 -3.5%
Value US$70,306
GREENWOOD DAVID EVP and CFO Officer
Transaction date
Sale
Price
7.20
Quantity 4,000 -2.2%
Value US$28,800
HARLEY CALVIN VP and CSO Officer
Transaction date
Sale
Price
9.13
Quantity 3,000 -5.0%
Value US$27,390
HARLEY CALVIN VP and CSO Officer
Transaction date
Sale
Price
9.15
Quantity 9,000 -13.0%
Value US$82,350
HARLEY CALVIN VP and CSO Officer
Transaction date
Sale
Price
9.21
Quantity 9,000 -11.5%
Value US$82,890
HARLEY CALVIN VP and CSO Officer
Transaction date
Sale
Price
9.22
Quantity 9,000 -10.3%
Value US$82,980
GREENWOOD DAVID Executive VP and CFO Officer
Transaction date
Sale
Price
8.56
Quantity 12,183 -41.8%
Value US$104,286
LEBKOWSKI JANE SVP, Regenerative Medicine Officer
Transaction date
Sale
Price
8.56
Quantity 10,676 -35.7%
Value US$91,387
EARP DAVID SVP Bus Dev / Chf Patent Couns Officer
Transaction date
Sale
Price
8.56
Quantity 11,323 -35.7%
Value US$96,925
HARLEY CALVIN Chief Scientific Officer Officer
Transaction date
Sale
Price
8.56
Quantity 9,183 -53.3%
Value US$78,606
BEHRS MELISSA KELLY VP, Oncology Officer
Transaction date
Sale
Price
8.56
Quantity 8,441 -53.4%
Value US$72,255
OKARMA THOMAS President and CEO Executive Director
Transaction date
Sale
Price
8.56
Quantity 12,320 -28.1%
Value US$105,459
KELLY MELISSA VP, Oncology Officer
Transaction date
Sale
Price
10.88
Quantity 19,532 -77.4%
Value US$212,508
KELLY MELISSA VP, Oncology Officer
Transaction date
Sale
Price
10.88
Quantity 46,039 -64.6%
Value US$500,904
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-19 2026-02-18 S Sale
4.1
ROBERTSON MICHELLE

EVP, CHIEF FINANCIAL OFFICER

Officer
12,502 -47.9%
294.90
US$1,889,238 		12,502 -47.9% 294.90 US$1,889,238
2025-12-15 2025-12-15 PrS Proposed sale
1.0
JAMES ZIEGLER

Officer

Officer
41,867
127.51
US$395,014 		41,867 127.51 US$395,014
2025-05-13 2025-05-09 B Purchase
3.1
LAWLIS V BRYAN
Non-Executive Director
23,533 +34.5%
242.44
US$2,231,583 		23,533 +34.5% 242.44 US$2,231,583
2025-03-03 2025-02-27 B Purchase
0.7
SCARLETT JOHN A

Chairman, President and CEO

Executive Director
12,500 +inf%
1.77
US$22,062 		12,500 +inf% 1.77 US$22,062
2025-03-03 2025-02-27 B Purchase
1.0
Ziegler James

EVP, Chief Commercial Officer

Officer
100,000 +inf%
1.60
US$160,000 		100,000 +inf% 1.60 US$160,000
2025-03-03 2025-02-27 B Purchase
1.0
Samuels Scott Alan

EVP, Chief Legal Officer

Officer
15,000 +128.4%
1.61
US$24,150 		15,000 +128.4% 1.61 US$24,150
2024-07-10 2024-07-08 S Sale
2.3
GRETHLEIN ANDREW J

EVP, Chief Operating Officer

Officer
674,348 -100.0%
4.56
US$3,073,004 		674,348 -100.0% 4.56 US$3,073,004
2024-07-08 2024-07-08 PrS Proposed sale
2.3
GRETHLEIN ANDREW J

Officer

Officer
674,348
4.35
US$2,933,414 		674,348 4.35 US$2,933,414
2024-06-12 2024-06-10 S Sale
2.7
Kapur Anil

EVP, Corp Strategy & CCO

Officer
421,875 -100.0%
4.65
US$1,959,609 		421,875 -100.0% 4.65 US$1,959,609
2024-06-12 2024-06-10 S Sale
2.7
Feller Faye

EVP, Chief Medical Officer

Officer
287,900 -100.0%
4.63
US$1,334,129 		287,900 -100.0% 4.63 US$1,334,129
2024-06-10 2024-06-10 PrS Proposed sale
2.7
Feller Faye

Officer

Officer
287,900
4.65
US$1,337,990 		287,900 4.65 US$1,337,990
2024-06-10 2024-06-10 PrS Proposed sale
2.7
Kapur Anil

Officer

Officer
421,875
4.65
US$1,961,941 		421,875 4.65 US$1,961,941
2024-06-05 2024-06-04 PlS Planned sale
0.7
SCARLETT JOHN A

Chairman, President and CEO

Executive Director
600,000 -50.0%
4.00
US$2,400,000 		600,000 -50.0% 4.00 US$2,400,000
2024-06-04 2024-06-04 PrS Proposed sale
0.7
JOHN A SCARLETT

Officer; Director

Executive Director
600,000
4.00
US$2,400,000 		600,000 4.00 US$2,400,000
2024-05-17 2024-05-15 PlS Planned sale
3.1
LAWLIS V BRYAN
Non-Executive Director
35,000 -100.0%
3.75
US$131,250 		35,000 -100.0% 3.75 US$131,250
2024-05-15 2024-05-15 PrS Proposed sale
3.1
BRYAN LAWLIS JR.

Director

Non-Executive Director
35,000
3.75
US$131,274 		35,000 3.75 US$131,274
2023-08-24 2023-08-24 B Purchase
2.5
O'Farrell Elizabeth G.
Non-Executive Director
6,579 +33.5%
2.28
US$15,000 		6,579 +33.5% 2.28 US$15,000
2023-08-24 2023-08-24 B Purchase
2.5
O'Farrell Elizabeth G.
Non-Executive Director
6,607 +825.9%
2.28
US$15,064 		6,607 +825.9% 2.28 US$15,064
2023-05-11 2023-05-11 PrS Proposed sale
3.1
BRYAN LAWLIS JR

Director

Non-Executive Director
35,000
3.00
US$105,000 		35,000 3.00 US$105,000
2023-05-11 2023-05-11 PlS Planned sale
3.1
LAWLIS V BRYAN
Non-Executive Director
35,000 -100.0%
3.00
US$105,000 		35,000 -100.0% 3.00 US$105,000
2023-05-01 2023-05-01 PrS Proposed sale
SUSAN MOLINEAUX

Director

Non-Executive Director
35,000
2.48
US$86,653 		35,000 2.48 US$86,653
2023-05-01 2023-05-01 PlS Planned sale
Molineaux Susan
Non-Executive Director
35,000 -100.0%
2.48
US$86,800 		35,000 -100.0% 2.48 US$86,800
2023-02-10 2023-02-10 PlS Planned sale
0.7
SCARLETT JOHN A

Chairman, President and CEO

Executive Director
446,668 -100.0%
3.00
US$1,340,004 		446,668 -100.0% 3.00 US$1,340,004
2023-02-10 2023-02-09 PlS Planned sale
2.3
GRETHLEIN ANDREW J

EVP, Chief Operating Officer

Officer
234,719 -100.0%
3.03
US$711,199 		234,719 -100.0% 3.03 US$711,199
2023-02-10 2023-02-09 PlS Planned sale
2.3
GRETHLEIN ANDREW J

EVP, Chief Operating Officer

Officer
150,000 -39.0%
3.03
US$454,500 		150,000 -39.0% 3.03 US$454,500
2023-02-10 2023-02-09 PlS Planned sale
0.7
SCARLETT JOHN A

Chairman, President and CEO

Executive Director
446,666 -100.0%
3.03
US$1,353,398 		446,666 -100.0% 3.03 US$1,353,398
2023-02-10 2023-02-08 PlS Planned sale
Bloom Olivia Kyusuk

EVP, Chief Financial Officer

Officer
400,000 -84.3%
3.08
US$1,232,000 		400,000 -84.3% 3.08 US$1,232,000
2023-02-10 2023-02-08 PlS Planned sale
0.7
SCARLETT JOHN A

Chairman, President and CEO

Executive Director
446,666 -100.0%
3.08
US$1,375,731 		446,666 -100.0% 3.08 US$1,375,731
2020-08-24 2020-08-21 B Purchase
2.5
O'Farrell Elizabeth G.
Non-Executive Director
17,441 +792.8%
1.73
US$30,173 		17,441 +792.8% 1.73 US$30,173
2020-01-13 2020-01-10 B Purchase
2.5
O'Farrell Elizabeth G.
2,200 +inf%
1.34
US$2,948 		2,200 +inf% 1.34 US$2,948
2020-01-13 2020-01-10 B Purchase
2.5
O'Farrell Elizabeth G.
800 +inf%
1.35
US$1,080 		800 +inf% 1.35 US$1,080
2019-04-10 2019-04-09 PlS Planned sale
BEHRS MELISSA KELLY

EVP, Chief Business Officer
120,635 -100.0%
2.00
US$241,270 		120,635 -100.0% 2.00 US$241,270
2018-09-13 2018-09-13 PlS Planned sale Spiegel Robert J. Non-Executive Director
35,000 -34.8%
6.85
US$239,750 		35,000 -34.8% 6.85 US$239,750
2018-09-13 2018-09-13 PlS Planned sale Spiegel Robert J. Non-Executive Director
35,000 -34.8%
6.85
US$239,750 		35,000 -34.8% 6.85 US$239,750
2018-09-13 2018-09-13 PlS Planned sale Spiegel Robert J. Non-Executive Director
35,000 -34.8%
6.85
US$239,750 		35,000 -34.8% 6.85 US$239,750
2018-09-13 2018-09-13 PlS Planned sale Spiegel Robert J. Non-Executive Director
15,000 -18.6%
6.85
US$102,750 		15,000 -18.6% 6.85 US$102,750
2018-09-13 2018-09-13 PlS Planned sale Spiegel Robert J. Non-Executive Director
10,000 -13.2%
6.85
US$68,500 		10,000 -13.2% 6.85 US$68,500
2018-09-13 2018-09-13 PlS Planned sale Spiegel Robert J. Non-Executive Director
45,000 -40.7%
6.85
US$308,250 		45,000 -40.7% 6.85 US$308,250
2018-08-24 2018-08-24 PlS Planned sale ROSENFIELD STEPHEN

EVP, Genl Counsel & Secretary

Officer
37,500 -100.0%
4.51
US$169,125 		37,500 -100.0% 4.51 US$169,125
2018-08-24 2018-08-24 PlS Planned sale ROSENFIELD STEPHEN

EVP, Genl Counsel & Secretary

Officer
112,500 -100.0%
4.51
US$507,375 		112,500 -100.0% 4.51 US$507,375
2018-08-24 2018-08-24 PlS Planned sale ROSENFIELD STEPHEN

EVP, Genl Counsel & Secretary

Officer
131,250 -100.0%
4.51
US$591,938 		131,250 -100.0% 4.51 US$591,938
2018-08-24 2018-08-24 PlS Planned sale ROSENFIELD STEPHEN

EVP, Genl Counsel & Secretary

Officer
420,000 -100.0%
4.51
US$1,894,200 		420,000 -100.0% 4.51 US$1,894,200
2018-08-24 2018-08-24 PlS Planned sale ROSENFIELD STEPHEN

EVP, Genl Counsel & Secretary

Officer
200,000 -100.0%
4.51
US$902,000 		200,000 -100.0% 4.51 US$902,000
2018-08-24 2018-08-24 PlS Planned sale ROSENFIELD STEPHEN

EVP, Genl Counsel & Secretary

Officer
425,000 -100.0%
4.51
US$1,916,750 		425,000 -100.0% 4.51 US$1,916,750
2018-08-24 2018-08-24 PlS Planned sale ROSENFIELD STEPHEN

EVP, Genl Counsel & Secretary

Officer
36,000 -100.0%
4.51
US$162,360 		36,000 -100.0% 4.51 US$162,360
2015-03-19 2015-03-18 S Sale Hofstaetter Thomas Non-Executive Director
70,000 -72.5%
4.10
US$287,000 		70,000 -72.5% 4.10 US$287,000
2014-05-12 2014-05-09 B Purchase BRADBURY DANIEL Non-Executive Director
142,776 +inf%
1.75
US$249,858 		142,776 +inf% 1.75 US$249,858
2013-04-01 2013-04-01 B Purchase SCARLETT JOHN A

President and CEO

Executive Director
50,000 +66.7%
1.03
US$51,500 		50,000 +66.7% 1.03 US$51,500
2013-01-22 2013-01-17 S Sale BEHRS MELISSA KELLY

SVP Alliance and Prog Mgmt

Officer
28,292 -100.0%
1.65
US$46,569 		28,292 -100.0% 1.65 US$46,569
2011-11-23 2011-11-22 B Purchase KILEY THOMAS Non-Executive Director
64,275 +25.7%
1.56
US$100,269 		64,275 +25.7% 1.56 US$100,269
2011-10-06 2011-10-05 B Purchase KILEY THOMAS Non-Executive Director
50,000 +107.2%
2.03
US$101,500 		50,000 +107.2% 2.03 US$101,500
2009-02-03 2009-02-02 S Sale BEHRS MELISSA KELLY

SVP Oncology

Officer
14,765 -100.0%
8.12
US$119,892 		14,765 -100.0% 8.12 US$119,892
2009-01-30 2009-01-30 S Sale WALKER JOHN PETER Non-Executive Director
48,617 -55.4%
8.28
US$402,549 		48,617 -55.4% 8.28 US$402,549
2009-01-30 2009-01-29 S Sale HARLEY CALVIN

VP and CSO

Officer
25,000 -20.1%
7.08
US$177,000 		25,000 -20.1% 7.08 US$177,000
2009-01-30 2009-01-29 S Sale HARLEY CALVIN

VP and CSO

Officer
5,489 -4.2%
7.14
US$39,191 		5,489 -4.2% 7.14 US$39,191
2008-11-05 2008-11-05 S Sale BEHRS MELISSA KELLY

SVP Oncology

Officer
23,845 -21.2%
4.05
US$96,572 		23,845 -21.2% 4.05 US$96,572
2008-01-04 2008-01-04 S Sale EARP DAVID

SVP Bus Dev, Chief Patnt Couns

Officer
8,911 -5.4%
5.34
US$47,585 		8,911 -5.4% 5.34 US$47,585
2008-01-04 2008-01-04 S Sale BEHRS MELISSA KELLY

SVP Oncology

Officer
8,911 -8.6%
5.34
US$47,585 		8,911 -8.6% 5.34 US$47,585
2008-01-04 2008-01-04 S Sale LEBKOWSKI JANE

SVP Regen Medicine

Officer
8,911 -5.7%
5.34
US$47,585 		8,911 -5.7% 5.34 US$47,585
2008-01-04 2008-01-04 S Sale GREENWOOD DAVID

EVP and CFO

Officer
11,039 -6.0%
5.34
US$58,948 		11,039 -6.0% 5.34 US$58,948
2008-01-04 2008-01-04 S Sale HARLEY CALVIN

VP and CSO

Officer
8,911 -6.9%
5.34
US$47,585 		8,911 -6.9% 5.34 US$47,585
2008-01-04 2008-01-04 S Sale OKARMA THOMAS

President and CEO

Officer
13,166 -3.5%
5.34
US$70,306 		13,166 -3.5% 5.34 US$70,306
2007-11-13 2007-11-12 S Sale GREENWOOD DAVID

EVP and CFO

Officer
4,000 -2.2%
7.20
US$28,800 		4,000 -2.2% 7.20 US$28,800
2007-05-21 2007-05-18 S Sale HARLEY CALVIN

VP and CSO

Officer
3,000 -5.0%
9.13
US$27,390 		3,000 -5.0% 9.13 US$27,390
2007-05-21 2007-05-18 S Sale HARLEY CALVIN

VP and CSO

Officer
9,000 -13.0%
9.15
US$82,350 		9,000 -13.0% 9.15 US$82,350
2007-05-21 2007-05-18 S Sale HARLEY CALVIN

VP and CSO

Officer
9,000 -11.5%
9.21
US$82,890 		9,000 -11.5% 9.21 US$82,890
2007-05-21 2007-05-18 S Sale HARLEY CALVIN

VP and CSO

Officer
9,000 -10.3%
9.22
US$82,980 		9,000 -10.3% 9.22 US$82,980
2006-01-10 2006-01-09 S Sale GREENWOOD DAVID

Executive VP and CFO

Officer
12,183 -41.8%
8.56
US$104,286 		12,183 -41.8% 8.56 US$104,286
2006-01-10 2006-01-09 S Sale LEBKOWSKI JANE

SVP, Regenerative Medicine

Officer
10,676 -35.7%
8.56
US$91,387 		10,676 -35.7% 8.56 US$91,387
2006-01-10 2006-01-09 S Sale EARP DAVID

SVP Bus Dev / Chf Patent Couns

Officer
11,323 -35.7%
8.56
US$96,925 		11,323 -35.7% 8.56 US$96,925
2006-01-10 2006-01-09 S Sale HARLEY CALVIN

Chief Scientific Officer

Officer
9,183 -53.3%
8.56
US$78,606 		9,183 -53.3% 8.56 US$78,606
2006-01-10 2006-01-09 S Sale BEHRS MELISSA KELLY

VP, Oncology

Officer
8,441 -53.4%
8.56
US$72,255 		8,441 -53.4% 8.56 US$72,255
2006-01-10 2006-01-09 S Sale OKARMA THOMAS

President and CEO

Executive Director
12,320 -28.1%
8.56
US$105,459 		12,320 -28.1% 8.56 US$105,459
2005-08-01 2005-07-29 S Sale KELLY MELISSA

VP, Oncology

Officer
19,532 -77.4%
10.88
US$212,508 		19,532 -77.4% 10.88 US$212,508
2005-08-01 2005-07-29 S Sale KELLY MELISSA

VP, Oncology

Officer
46,039 -64.6%
10.88
US$500,904 		46,039 -64.6% 10.88 US$500,904
Explore more

More insider trading research around Geron Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America